National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors

GlobeNewswire• January 29, 2019 The drug delivery leader taps former COO of U.S. Centers for Medicare & Medicaid Services to join growing Board OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board of Directors. King-Shaw brings…